|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000883273 |
| 003 |
SK-MaSNL |
| 005 |
20260304130332.0 |
| 008 |
250429c2004 xo 0 slo |
| 015 |
|
|
|a SNBRB2004/09-26633
|
| 035 |
|
|
|a CLN000234749
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab71tr
|
| 035 |
|
|
|a (uuid)c241e2ef-095a-4dc1-8e2a-1939e0ae8992
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06mqr
|
| 035 |
|
|
|a (sysno)vtls000883273
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 615.2:577.175.5:061.3
|2 1997
|
| 245 |
0 |
0 |
|a Effects of inhaled budesonid on glucose metabolism and plasma cortisol
|c J. Plutinský ... [et al.]
|
| 650 |
0 |
7 |
|a javy biochemické, metabolizmus a výživa
|2 MESH
|9 845126
|
| 650 |
0 |
7 |
|a samomonitorovanie krvnej glukózy
|2 MESH
|9 1441057
|
| 650 |
0 |
7 |
|a lipoproteíny, HDL-cholesterol
|x analýza
|x použitie diagnostické
|2 MESH
|9 1441058
|
| 650 |
0 |
7 |
|a budezonid
|x aplikácia a dávkovanie
|x farmakokinetika
|2 MESH
|9 1441059
|
| 650 |
0 |
7 |
|a lipoproteíny, LDL-cholesterol
|x analýza
|x použitie diagnostické
|2 MESH
|9 1441060
|
| 650 |
0 |
7 |
|a abstrakty z kongresu
|2 MESH
|9 168204
|
| 650 |
0 |
7 |
|a astma
|x diagnostika
|x farmakoterapia
|2 MESH
|9 1439460
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 700 |
1 |
|
|a Magula, Daniel
|4 aut
|9 350224
|
| 700 |
1 |
|
|a Plutinský, Ján
|4 aut
|9 745856
|
| 700 |
1 |
|
|a Petríček, Štefan,
|d 1948-
|4 aut
|9 256454
|
| 700 |
1 |
|
|a Očkovská, V.
|4 aut
|9 1174470
|
| 700 |
1 |
|
|a Peskovicová, D.
|4 aut
|9 772902
|
| 773 |
0 |
|
|t Klinická imunológia a alergológia
|g Zv. 14, č. 1 (2004), s. 35
|x 1335-0013
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 954 |
|
|
|a odborná, vedecká literatúra pôvodná (slovenská)
|2 lita
|
| 958 |
|
|
|a article27
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 999 |
|
|
|c 2895367
|d 2897297
|
